B2

Specifications

115687-05-3CAS Number

634-212-5EC Number

(4-chlorophenyl)-[4-(8-nitroquinolin-5-yl)piperazin-1-yl]methanoneIUPAC Name

C20H17ClN4O3Chemical Formula

396.8 g/molMolecular Weight

115687-05-3; (4-chlorophenyl)-[4-(8-nitroquinolin-5-yl)piperazin-1-yl]methanone; DTXSID30398200; RefChem:402685; DTXCID70349059; CPNQ; (4-chlorophenyl)(4-(8-nitroquinolin-5-yl)piperazin-1-yl)methanone; B2; SIRT2-IN-8; 5-[4-(4-chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline; Methanone, (4-chlorophenyl)[4-(8-nitro-5-quinolinyl)-1-piperazinyl]-; CHEMBL226115; (4-chlorophenyl)[4-(8-nitroquinolin-5-yl)piperazin-1-yl]methanone; B2; (4-Chlorophenyl)[4-(8-nitro-5-quinolinyl)-1-piperazinyl]methanone; CPNQ;; SIRT2 Inhibitor, B2; CBMicro_046888; Oprea1_532455; orb1305874; orb1940383; SCHEMBL6267516; SCHEMBL29943849; CHEBI:125473; HMS3261L20; QEA68705; Tox21_500619; BDBM50216685; CPNQ, >=98% (HPLC), solid; MFCD02039810; AKOS000424462; AKOS040745134; Linazolamide intermediate B impurity 2; LP00619; SDCCGSBI-0046858.P002; NCGC00186018-01; NCGC00261304-01; BS-52744; DA-50919; ST073924; BIM-0046858.P001; HY-107660; CS-0029082; EU-0040310; E77878; T22595; F861571; SR-01000452429; SR-01000452429-1; BRD-K04722205-001-01-1; Q27216092; 4-chlorophenyl 4-(8-nitro(5-quinolyl))piperazinyl ketone; (4-chlorophenyl)-[4-(8-nitro-5-quinolinyl)-1-piperazinyl]methanone; (4-chlorophenyl)-[4-(8-nitro-5-quinolyl)piperazin-1-yl]methanone; Sirtuin,Parkinson's diseases,Huntington's diseases,Inhibitor,B2,inhibit,B-2; CPNQ; BP 554 maleate; 5-[4-(4-chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline B2;Synonyms